Beijing Hotgen Biotech Co., Ltd. (688068.SS)
CNY 52.76
(-1.59%)
CNY 52.76
(-1.59%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 541.25 Million | 3.55 Billion | 5.36 Billion | 513.53 Million | 210.41 Million | 187.12 Million |
| Cost of Revenue | 232.99 Million | 1.64 Billion | 2.17 Billion | 189.94 Million | 56.54 Million | 49.13 Million |
| Gross Profit | 308.25 Million | 1.91 Billion | 3.19 Billion | 323.58 Million | 153.86 Million | 137.99 Million |
| Operating Expenses | 314.19 Million | 671.1 Million | 524.82 Million | 203.91 Million | 116.55 Million | 82.74 Million |
| Selling, General and Administrative Expenses | 249.73 Million | 420.42 Million | 277.4 Million | 133.16 Million | 83.57 Million | 61.59 Million |
| Research and Development Expenses | 131.44 Million | 191.13 Million | 131.91 Million | 47.61 Million | 28.99 Million | 18.38 Million |
| Other Expenses | -66.98 Million | 59.53 Million | 115.5 Million | 23.13 Million | 3.98 Million | -309.73 Thousand |
| Cost and Expenses | 524.04 Million | 2.31 Billion | 2.69 Billion | 393.86 Million | 173.1 Million | 131.87 Million |
| Operating Income | 17.21 Million | 1.09 Billion | 2.58 Billion | 127.95 Million | 37.37 Million | 55.8 Million |
| Interest Expense | 1.11 Million | 2.31 Million | 1.27 Million | 445.9 Thousand | 1.03 Million | 3275.87 |
| Income Tax Expense | -1.54 Million | 150.1 Million | 379.43 Million | 16.12 Million | 4.11 Million | 7.31 Million |
| Earnings before Tax | 14.93 Million | 1.07 Billion | 2.58 Billion | 127.42 Million | 37.86 Million | 55.49 Million |
| Net Income | 27.38 Million | 944.73 Million | 2.18 Billion | 112.06 Million | 33.87 Million | 48.14 Million |
| Earnings Per Share Basic | 0.31 | 10.55 | 23.75 | 1.22 | 0.37 | 0.70 |
| Earnings Per Share Diluted | 0.31 | 10.28 | 23.75 | 1.22 | 0.37 | 0.70 |
| Weighted Average Shares Outstanding | 88.33 Million | 89.53 Million | 92.05 Million | 92.05 Million | 92.05 Million | 69.17 Million |
| Weighted Average Shares Outstanding (Diluted) | 88.33 Million | 91.9 Million | 92.05 Million | 92.05 Million | 92.05 Million | 69.17 Million |
| Gross Margin | 0.57 | 0.54 | 0.60 | 0.63 | 0.73 | 0.74 |
| EBIT Margin | 0.16 | 0.39 | 0.52 | 0.31 | 0.30 | 0.39 |
| Profit Margin | 0.05 | 0.27 | 0.41 | 0.22 | 0.16 | 0.26 |
| EBITDA | 85.04 Million | 1.19 Billion | 2.65 Billion | 157.01 Million | 64.38 Million | 78.54 Million |
| Earnings Before Tax Margin | 0.03 | 0.31 | 0.48 | 0.25 | 0.18 | 0.30 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 136.24 Million | 132.68 Million | 116.12 Million | 134.22 Million | 541.14 Million | 99.9 Million |
| Cost of Revenue | 59.2 Million | 76.89 Million | 47.56 Million | 86.9 Million | 232.99 Million | 42.11 Million |
| Gross Profit | 77.04 Million | 55.78 Million | 68.55 Million | 47.32 Million | 308.15 Million | 57.79 Million |
| Operating Expenses | 91.92 Million | 94.66 Million | 82.34 Million | 198.64 Million | 559.78 Million | 101.96 Million |
| Selling, General and Administrative Expenses | 66.74 Million | 46.76 Million | 60.57 Million | 28.45 Million | - | 92.22 Million |
| Research and Development Expenses | 27.55 Million | 26.97 Million | 22.66 Million | 32.27 Million | - | 31.05 Million |
| Other Expenses | 2.36 Million | -666.59 Thousand | -342.03 Thousand | -198.64 Million | -559.78 Million | -1.13 Million |
| Cost and Expenses | 151.13 Million | 171.56 Million | 129.91 Million | 198.64 Million | 559.78 Million | 144.08 Million |
| Operating Income | -14.88 Million | -47.5 Million | 5.44 Million | -64.41 Million | -18.63 Million | -39.8 Million |
| Interest Expense | - | - | - | - | 1 Million | - |
| Income Tax Expense | 2.23 Million | 1.01 Million | 1.57 Million | 237.23 Thousand | -1.54 Million | -11.47 Million |
| Earnings before Tax | 17.95 Million | -48.17 Million | 5.1 Million | -30.21 Million | 14.93 Million | -40.93 Million |
| Net Income | 2.82 Million | -48.52 Million | 5.05 Million | -16.77 Million | 27.38 Million | -30.38 Million |
| Earnings Per Share Basic | 0.03 | -0.56 | 0.06 | -0.20 | - | -0.34 |
| Earnings Per Share Diluted | 0.03 | -0.56 | 0.06 | -0.20 | - | -0.34 |
| Weighted Average Shares Outstanding | 86.72 Million | 86.99 Million | 84.24 Million | 85.88 Million | 88.33 Million | 89.53 Million |
| Weighted Average Shares Outstanding (Diluted) | 86.72 Million | 86.99 Million | 84.24 Million | 85.88 Million | 88.33 Million | 89.53 Million |
| Gross Margin | 0.57 | 0.42 | 0.59 | 0.35 | 0.57 | 0.58 |
| EBIT Margin | 0.13 | -0.04 | -0.26 | -0.03 | - | -0.69 |
| Profit Margin | 0.02 | -0.37 | 0.04 | -0.12 | 0.05 | -0.30 |
| EBITDA | 17.95 Million | -5.32 Million | -30.4 Million | -3.48 Million | - | -68.88 Million |
| Earnings Before Tax Margin | -0.11 | -0.36 | 0.05 | -0.48 | -0.03 | -0.40 |
CPLE5
600339
VNORP
LOT
TOPP
MSGCF